GLP1-RAs and Type 1 Diabetes: A retrospective study of incretin-based therapy use with Open Source AID.
So far in this series we’ve looked at why incretin therapy might be a useful adjunct to traditional type 1 treatment, and also how the […]
Month: October 2024
GLP1-RAs in Type 1 Diabetes: Dosing and Pharmacokinetics
As we discussed in the previous article, people are starting to use incretins as an adjunct therapy in the treatment of type 1 diabetes. All […]
GLP1-RAs in Type 1 Diabetes: more than meets the eye?
Some people will be aware, and some not, that there is a reasonable minority of people with Type 1 Diabetes using GLP-1 Receptor Agonists (GLP1-RAs) […]